SCHEMBL11264437

SCHEMBL11264437

Nc1c(Br)cc(C(=O)OCCCl)cc1CNCCCC1CCCCC1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SIGMAR1 Q99720 1/20 0.33
▸ HRH4 Q9H3N8 3/20 0.32
▸ HRH3 Q9Y5N1 3/20 0.32
▸ ESR1 P03372 1/20 0.32
▸ EPHX1 P07099 1/20 0.32
▸ AAK1 Q2M2I8 2/20 0.31
▸ KIT P10721 1/20 0.30
▸ MAPK14 Q16539 1/20 0.30
▸ NAAA Q02083 3/20 0.30
▸ CXCR4 P61073 1/20 0.30
▸ TDP1 Q9NUW8 1/20 0.30
▸ LMNA P02545 1/20 0.30
▸ GBA1 P04062 1/20 0.30
▸ CYP1A2 P05177 1/20 0.30
▸ CYP2D6 P10635 1/20 0.30
▸ CNR1 P21554 1/20 0.30
▸ TBXA2R P21731 1/20 0.30
▸ HRH2 P25021 1/20 0.30
▸ SLC6A4 P31645 1/20 0.30
▸ KCNH2 Q12809 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11160453 0.94 EPHX1 (0.35) SIGMAR1HRH4HRH3ESR1EPHX1
SCHEMBL11155609 0.94 EPHX1 (0.34) SIGMAR1HRH4HRH3ESR1EPHX1
SCHEMBL11168503 0.91 SIGMAR1 (0.34) SIGMAR1HRH4HRH3ESR1EPHX1
SCHEMBL11265198 0.89 EPHX1 (0.35) SIGMAR1HRH4HRH3ESR1EPHX1
SCHEMBL11172342 0.80 HDAC6 (0.39) ESR1AAK1TDP1LMNAGBA1
SCHEMBL11272325 0.80 MAPT (0.33) AAK1KITMAPK14TDP1LMNA
SCHEMBL11149398 0.79 HDAC6 (0.37) ESR1EPHX1AAK1TDP1LMNA
SCHEMBL11272015 0.79 TTR (0.42) LMNATBXA2RHIF1AKMT2A
SCHEMBL11405698 0.79 PTGS2 (0.42) LMNAHIF1APPM1D
SCHEMBL11155491 0.78 HDAC6 (0.36) ESR1AAK1LMNAGBA1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4362738-A ANTIINFLAMMATORIES DR. KARL THOMAE GMBH (DE) 1982-12-07 — — US disclosed
Send feedback